Drugs / DiaResQ Children's Powder for Suspension
DiaResQ Children's Powder for Suspension
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04885049 | Sep 2021 → Feb 2022 | diarrheal disease | Shaheed Zulfiqar Ali Bhutto Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DiaResQ Children's Powder for Suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04885049 ↗ |
| Modality | Protein / enzyme biologic | “bovine immunoglobulins” NCT04885049 ↗ |
| Route | Oral | “taken orally once daily for 3 days” NCT04885049 ↗ |